Skip to main content

WT/DS114 - Canada - Patent protection of pharmaceutical products

WTO dispute settlement case - Launched by the EU

Country or region
Trade topics
Dispute settlement
Dispute settlement
WTO - Case launched by the EU

Summary of the case

  • Complaint by: EU
  • Complaint against: Canada
  • Third parties: Austria, Brazil, Colombia, Cuba, India, Israel, Japan, Poland, Switzerland, Thailand, United States

Canada allows for start of commercial manufacture of patented medicines 6 months before the expiry of the patent and the manufacturing of the product for the purpose of securing the approval of generic medicines ("regulatory exception")

Relevant WTO provision: TRIPS (27.1, 28, 30, 33)


EC prevailed on stockpiling exception. Implementation period (6 Months) determined by arbitration, ends on 7 Oct. 2000.

  • Consultations requested: 19 December 1997
  • Panel requested: 11 November 1998
  • Panel established: 01 February 1999
  • Panel report circulated: 17 March 2003
  • Panel/Appellate Body report adopted: 07 April 2000
  • Implementation deadline: 07 October 2000


Full case details and WTO documents on the WTO website

Latest news

  • Press release

EU wins WTO compliance action against US in ripe olives dispute

The World Trade Organization (WTO) has today confirmed that the EU was right to challenge the US for not complying with a ruling relating to ripe olives from Spain. Today's WTO panel report presents again a clear and full win for the EU.

Latest events